Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploring biologically relevant chemical space with metal complexes.

Eric Meggers1

  • 1Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, PA 19104, USA. meggers@sas.upenn.edu

Current Opinion in Chemical Biology
|June 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imidazol-2-ylidene-Based NCCN Ligands for Chiral-at-Iron Catalysis.

Organometallics·2026
Same author

Asymmetric Iron-Catalyzed Vicinal C(sp<sup>3</sup>)─H Diamination of Carboxylic Acids.

Angewandte Chemie (International ed. in English)·2026
Same author

An Achiral Tetradentate Cis-α-Coordinating NCCN Ligand Gives Rise to a Configurationally Stable Chiral-at-Iron Complex for Enantioselective Catalysis.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Cobalt catalyst with exclusive metal-centered chirality for asymmetric photocatalysis.

Nature communications·2025
Same author

Development of Chiral-At-Ruthenium Mesoionic Carbene Catalysts.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Chiral-at-metal catalysts: history, terminology, design, synthesis, and applications.

Chemical Society reviews·2025

Metal complexes can be used to create novel, shape-defined molecules for drug discovery. This approach complements traditional organic chemistry, expanding the toolkit for designing new therapeutic agents and molecular probes.

Area of Science:

  • Inorganic chemistry
  • Medicinal chemistry
  • Chemical biology

Background:

  • Small synthetic molecules are key for drugs and probes, with organic molecules dominating.
  • Inorganic compounds are typically used for reactivity (e.g., cisplatin) or imaging (e.g., gadolinium complexes).
  • Coordination chemistry is central to the action of current inorganic pharmaceuticals.

Purpose of the Study:

  • To explore metal complexes for designing 'organic-like' small-molecule probes and drugs.
  • To leverage the structural organization capabilities of metal ions.
  • To complement organic chemistry's molecular diversity in drug discovery.

Main Methods:

  • Utilizing metal ions to organize organic ligands in 3D space.
  • Designing metal-organic compounds with defined shapes.

Related Experiment Videos

  • Investigating the biological activities of these novel compounds.

    • Main Results:

    • Metal complexes can form unique, defined structures.
    • These structures can mimic organic small molecules.
    • This approach offers a new avenue for discovering compounds with enhanced biological activities.

    Conclusions:

    • Metal-organic compounds represent a promising strategy for drug and probe design.
    • This approach expands the scope beyond traditional organic medicinal chemistry.
    • The structural control offered by metal ions can lead to novel therapeutic agents.